BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29523824)

  • 21. A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism.
    Trebosc V; Gartenmann S; Royet K; Manfredi P; Tötzl M; Schellhorn B; Pieren M; Tigges M; Lociuro S; Sennhenn PC; Gitzinger M; Bumann D; Kemmer C
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7263-7271. PubMed ID: 27671072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic Role of Biofilm-Associated Genes and Efflux Pump Genes in Tigecycline Resistance of Acinetobacter baumannii.
    Luo B; Li Z; Wang Q; Wang C
    Med Sci Monit; 2023 Sep; 29():e940704. PubMed ID: 37688296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance.
    Lin MF; Lin YY; Tu CC; Lan CY
    J Microbiol Immunol Infect; 2017 Apr; 50(2):224-231. PubMed ID: 26055688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diversity of mutations in regulatory genes of resistance-nodulation-cell division efflux pumps in association with tigecycline resistance in Acinetobacter baumannii.
    Gerson S; Nowak J; Zander E; Ertel J; Wen Y; Krut O; Seifert H; Higgins PG
    J Antimicrob Chemother; 2018 Jun; 73(6):1501-1508. PubMed ID: 29554339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmid borne Carbapenem-Hydrolyzing Class D β-Lactamases (CHDLs) and AdeABC efflux pump conferring carbapenem-tigecycline resistance among Acinetobacter baumannii isolates harboring TnAbaRs.
    Savari M; Ekrami A; Shoja S; Bahador A
    Microb Pathog; 2017 Mar; 104():310-317. PubMed ID: 28137509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COMPARISON OF TWO DIFFERENT METHODS FOR TIGECYCLINE SUSCEPTIBILITY TESTING IN
    Bedenić B; Cavrić G; Vranić-Ladavac M; Barišić N; Karčić N; Tot T; Presečki-Stanko A; Lukić-Grlić A; Frančula-Zaninović S; Sreter KB
    Acta Clin Croat; 2018 Dec; 57(4):618-623. PubMed ID: 31168197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations.
    Yoon EJ; Courvalin P; Grillot-Courvalin C
    Antimicrob Agents Chemother; 2013 Jul; 57(7):2989-95. PubMed ID: 23587960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Ruzin A; Keeney D; Bradford PA
    J Antimicrob Chemother; 2007 May; 59(5):1001-4. PubMed ID: 17363424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
    Liu B; Bai Y; Liu Y; Di X; Zhang X; Wang R; Wang J
    J Chemother; 2015 Oct; 27(5):271-6. PubMed ID: 25068186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spread of tet(X5) and tet(X6) genes in multidrug-resistant Acinetobacter baumannii strains of animal origin.
    Chen C; Cui CY; Wu XT; Fang LX; He Q; He B; Long TF; Liao XP; Chen L; Liu YH; Sun J
    Vet Microbiol; 2021 Feb; 253():108954. PubMed ID: 33373881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of insertion sequence Aba-1 and AdeS in reduced tigecycline susceptibility in MDR-Acinetobacter baumannii clinical isolates from Cairo, Egypt.
    Hassan R; Mukhtar A; Hasanin A; Ghaith D
    J Chemother; 2018 Apr; 30(2):89-94. PubMed ID: 29108486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of efflux pumps in resistance to tigecycline in Acinetobacter baumannii].
    Qu J; Ye H; Yu R; Lü X
    Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(46):3661-5. PubMed ID: 25622961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating multi-drug resistant Acinetobacter baumannii isolates at a tertiary hospital in Pretoria, South Africa.
    Nogbou ND; Phofa DT; Nchabeleng M; Musyoki AM
    Indian J Med Microbiol; 2021 Apr; 39(2):218-223. PubMed ID: 33832811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital.
    Deng M; Zhu MH; Li JJ; Bi S; Sheng ZK; Hu FS; Zhang JJ; Chen W; Xue XW; Sheng JF; Li LJ
    Antimicrob Agents Chemother; 2014; 58(1):297-303. PubMed ID: 24165187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates.
    Ricciardi R; Ricciardi AM; Danzi G
    Infez Med; 2009 Dec; 17(4):236-9. PubMed ID: 20046104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
    Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
    Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of Resistance, Clonal Expansion, and Increasing Prevalence of Acinetobacter baumannii Strains Displaying Elevated Tigecycline MIC Values in Latin America.
    Costello SE; Gales AC; Morfin-Otero R; Jones RN; Castanheira M
    Microb Drug Resist; 2016 Jun; 22(4):253-8. PubMed ID: 26716768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acinetobacter baumannii Repeatedly Evolves a Hypermutator Phenotype in Response to Tigecycline That Effectively Surveys Evolutionary Trajectories to Resistance.
    Hammerstrom TG; Beabout K; Clements TP; Saxer G; Shamoo Y
    PLoS One; 2015; 10(10):e0140489. PubMed ID: 26488727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii.
    Ni W; Wang Y; Ma X; He Y; Zhao J; Guan J; Li Y; Gao Z
    Eur J Clin Microbiol Infect Dis; 2022 Dec; 41(12):1451-1457. PubMed ID: 36201141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic Variability of AdeRS Two-Component System Associated with Tigecycline Resistance in XDR-Acinetobacter baumannii Isolates.
    Montaña S; Vilacoba E; Traglia GM; Almuzara M; Pennini M; Fernández A; Sucari A; Centrón D; Ramírez MS
    Curr Microbiol; 2015 Jul; 71(1):76-82. PubMed ID: 25941024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.